Dexcom’s core product is the Continuous Glucose Monitor (CGM), which tracks blood sugar levels 24/7 by attaching a sensor to the body. This device is crucial for diabetes management, especially for patients who need regular insulin injections, as it provides continuous data instead of the traditional finger-prick method.
Dexcom’s stock dropped by 40% in July due to a combination of factors, including a slowdown in new customer acquisition in the U.S., challenges in shifting their sales strategy towards pharmacies, and increased competition from Abbott, which has a more aggressive pricing and market penetration strategy.
Abbott focuses on affordability and accessibility, targeting a broader market including Type 2 diabetes patients and wellness enthusiasts. Their Freestyle Libre product is significantly cheaper and easier to obtain, which contrasts with Dexcom’s focus on higher-end, prescription-based devices for Type 1 and severe Type 2 diabetes patients.
In 2021, there were approximately 530 million adults with diabetes globally, a number expected to double by 2050. This growing prevalence underscores the importance of CGMs like those produced by Dexcom and Abbott, which help manage diabetes by providing continuous glucose monitoring, thereby preventing complications such as heart disease and stroke.
Dexcom faces challenges such as high product costs, slower international expansion compared to Abbott, and the need to adapt its sales strategy to include pharmacies and broader Type 2 diabetes market segments. Additionally, the competitive pressure from Abbott’s aggressive pricing and market strategies further complicates Dexcom’s growth.
本集節目由【ZENLET 掛繩二刀流)】贊助 你是不是常覺得手機和識別證總是不好收納?Zenlet 掛繩二刀流),幫你一次搞定!這款結合手機掛繩與識別證夾的創新神器,讓行動派的你隨時隨地輕鬆切換工作與休閒模式,效率加倍,空間解放! 掛繩二刀流特色: 📱 單手俐落:德國專利磁吸扣件,單手裝/拆手機 📏 隨心調節:拉一下變斜背,滑一下回頸掛 🔬 衛生舒適:圓繩添加抗菌銀離子,防止細菌孳生 🖇 模組化證件夾:橫直式自由切換,還能升級鈔票名片夾 ⏳ 限時 95 折優惠進行中,快透過專屬網址了解更多:https://shop.zenlet.co/pages/the-dual/?sl-ref=manny2) -- (00:00) AI 解決不了的鳥事 (12:45) 前言與致謝 (16:42) 糖尿病與 CGM 的簡介 (24:21) Dexcom 的前世今生 (34:32) Abbott 的彎道超車 (43:55) 雙頭寡斷的競爭格局 (49:24) Dexcom 的因應策略 (56:47) Abbott 的進攻策略 (01:02:36) 潛在的市場破壞力 -- 感謝余鎮文(Vincent)帶領以下台大國企系同學協助製作本集節目:李宇為、王若薇、蔡佳蓁、林均、趙振泓、王鼎鈞、吳承豪、吳政諒 -- 我們唯一使用的筆記軟體:Heptabase 立刻試用:https://get.heptabase.com/0riyv036mxrp -- 商業合作報價:https://manny-li.com/sponsor/ 訂閱電子報:https://manny-li.com 追蹤 IG:@manny_li 追蹤 FB:manny yh li Powered by Firstory Hosting)